BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

811 related articles for article (PubMed ID: 19099711)

  • 21. Effectiveness of moderate dose combination chemotherapy in Burkitt's lymphoma.
    Patel JG; Pandita R; al-Jazzaf H; Mechl Z; al-Jarallah MA
    Neoplasma; 1993; 40(3):185-8. PubMed ID: 8350967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status: final results of a phase 2 study (Burkimab).
    Ribera JM; García O; Grande C; Esteve J; Oriol A; Bergua J; González-Campos J; Vall-Llovera F; Tormo M; Hernández-Rivas JM; García D; Brunet S; Alonso N; Barba P; Miralles P; Llorente A; Montesinos P; Moreno MJ; Hernández-Rivas JÁ; Bernal T
    Cancer; 2013 May; 119(9):1660-8. PubMed ID: 23361927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Burkitt's lymphoma in adults: a retrospective study of 46 cases.
    Ostronoff M; Soussain C; Zambon E; Ibrahim A; Bosq J; Bayle C; Pico JL; Gilles E; Moran A; Droz JP
    Nouv Rev Fr Hematol (1978); 1992; 34(5):389-97. PubMed ID: 1296192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of p53 mutations in newly diagnosed Burkitt's lymphoma and acute lymphoblastic leukemia: a report of 48 cases.
    Preudhomme C; Dervite I; Wattel E; Vanrumbeke M; Flactif M; Lai JL; Hecquet B; Coppin MC; Nelken B; Gosselin B
    J Clin Oncol; 1995 Apr; 13(4):812-20. PubMed ID: 7707106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Burkitt's lymphoma in Europe.
    Philip T
    IARC Sci Publ; 1985; (60):107-18. PubMed ID: 2998984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Burkitt's lymphoma/leukemia: a clinicopathologic study on 24 adult patients.
    Bernasconi C; Brusamolino E; Pagnucco G; Bernasconi P; Orlandi E; Lazzarino M
    Leukemia; 1991; 5 Suppl 1():90-4. PubMed ID: 1890873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapy of advanced-stage mature B-cell lymphoma and leukemia in children and adolescents with rituximab and reduced intensity induction chemotherapy (B-NHL 2004M protocol): the results of a multicenter study.
    Samochatova EV; Maschan AA; Shelikhova LN; Myakova NV; Belogurova MB; Khlebnikova OP; Shamardina AV; Ryskal OV; Roumiantseva JV; Konovalov DM; Dubrovina ME; Rumyantsev AG
    J Pediatr Hematol Oncol; 2014 Jul; 36(5):395-401. PubMed ID: 23823112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcome is unchanged by adding vincristine upfront to the Malawi 28-day protocol for endemic Burkitt lymphoma.
    Depani S; Banda K; Bailey S; Israels T; Chagaluka G; Molyneux E
    Pediatr Blood Cancer; 2015 Nov; 62(11):1929-34. PubMed ID: 26052841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical pathologic characteristics and treatment outcomes of 19 relapsed pediatric B-cell lymphoma].
    Huang S; Jin L; Yang J; Duan YL; Zhang M; Zhou CJ; Ma XL; Zhang YH
    Zhonghua Er Ke Za Zhi; 2017 Oct; 55(10):748-753. PubMed ID: 29050112
    [No Abstract]   [Full Text] [Related]  

  • 30. Advanced stage (III-IV) Burkitt's lymphoma and B-cell acute lymphoblastic leukaemia in children: kinetic and pharmacologic rationale for treatment and recent results (1979-1983).
    Murphy SB; Bowman WP; Hustu HO; Berard CW
    IARC Sci Publ; 1985; (60):405-18. PubMed ID: 3905592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aggressive chemotherapy in the treatment of Burkitt's and non-Burkitt's undifferentiated lymphoma.
    Mazza JJ; Hines JD; Andersen JW; Neiman RS; Mann R; Oken MM; O'Connell MJ
    Leuk Lymphoma; 1995 Jul; 18(3-4):289-96. PubMed ID: 8535195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intensive short-term chemotherapy regimen induces high remission rate (over 90%) and event-free survival both in children and adult patients with advanced sporadic Burkitt lymphoma/leukemia.
    Todeschini G; Bonifacio M; Tecchio C; Balter R; Carli G; Stefani PM; Adami F; Zamò A; Dei Tos AP; Marino F; Gherlinzoni F; Marradi P; Semenzato G; Pizzolo G
    Am J Hematol; 2012 Jan; 87(1):22-5. PubMed ID: 22086870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma.
    Wang ES; Straus DJ; Teruya-Feldstein J; Qin J; Portlock C; Moskowitz C; Goy A; Hedrick E; Zelenetz AD; Noy A
    Cancer; 2003 Sep; 98(6):1196-205. PubMed ID: 12973843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study.
    Mead GM; Sydes MR; Walewski J; Grigg A; Hatton CS; Pescosta N; Guarnaccia C; Lewis MS; McKendrick J; Stenning SP; Wright D;
    Ann Oncol; 2002 Aug; 13(8):1264-74. PubMed ID: 12181251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Long-lasting remission of Burkitt's disease in African children. Apropos of 6 cases].
    Plo JK; Rain JD; Andoh J; Tea DN; Essoh NP
    Med Trop (Mars); 1986; 46(2):141-6. PubMed ID: 3724411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Undifferentiated non-Hodgkin's lymphomas (Burkitt's and non-Burkitt's types). The relevance of making this histologic distinction.
    Miliauskas JR; Berard CW; Young RC; Garvin AJ; Edwards BK; DeVita VT
    Cancer; 1982 Nov; 50(10):2115-21. PubMed ID: 7127252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical Analysis of 41 Patients with Burkitt's lymphoma].
    Ding J; Wang LX; Zhao XL; Wang LJ; Li DD; Yao YS; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Apr; 23(2):425-30. PubMed ID: 25948198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rituximab-combination chemotherapy achieves a 10th cycle of remission for Burkitt's lymphoma.
    Umeda K; Fujino H; Saida S; Kato I; Hiramatsu H; Yamada T; Hori T; Adachi S; Heike T; Watanabe K
    Pediatr Int; 2015 Apr; 57(2):e30-3. PubMed ID: 25868956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of residual abdominal masses in children with abdominal Burkitt's lymphoma.
    Karmazyn B; Ash S; Goshen Y; Yaniv I; Horev G; Kornreich L
    Pediatr Radiol; 2001 Nov; 31(11):801-5. PubMed ID: 11692238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Rectal localization of Burkitt's lymphoma].
    Blanc S; Bertrand Y; Lorthois-Ninou S; Carlioz P; Dijoud F; Pracros JP
    Arch Pediatr; 2002 Oct; 9(10):1056-8. PubMed ID: 12462838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.